Cargando…
Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers
Advanced osteosarcomas (OSs) and Ewing sarcomas (ESs) tend to have poor prognosis with limited therapeutic options beyond first-line therapy. Aberrant angiogenesis and MET signaling play an important role in preclinical models. The anti-angiogenic drug cabozantinib was tested in a phase 2 trial of a...
Autores principales: | Kokkali, Stefania, Kyriazoglou, Anastasios, Mangou, Elpida, Economopoulou, Panagiota, Panousieris, Michail, Psyrri, Amanda, Ardavanis, Alexandros, Vassos, Nikolaos, Boukovinas, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918141/ https://www.ncbi.nlm.nih.gov/pubmed/36769769 http://dx.doi.org/10.3390/jcm12031119 |
Ejemplares similares
-
Brain Metastases from Adult Sarcomas: A Retrospective Cohort Study from the Hellenic Group of Sarcomas and Rare Cancers (HGSRC)
por: Kokkali, Stefania, et al.
Publicado: (2021) -
Tyrosine kinase inhibitors in sarcoma treatment
por: Kyriazoglou, Anastasios, et al.
Publicado: (2022) -
Systematic Review of Recurrent Osteosarcoma Systemic Therapy
por: Gazouli, Ioanna, et al.
Publicado: (2021) -
Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017) -
Cerebral metastasis from osteosarcoma: “Bone” in the brain
por: Kokkali, Stefania, et al.
Publicado: (2020)